Skip to main content

Turnstone Biologics Corp.

TSBXDelisted Aug 11, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001764974

Turnstone Biologics Corp. was delisted on Aug 11, 2025; its insiders filed their last Form 4 on Aug 12, 2025; 23 institutions reported holding it in 13F filings for Q2 2025, worth $3.03M in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding Turnstone Biologics Corp. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of TSBX: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders47124−22
Shares12.7M41.3K11.4M−1.22M (−9.6%)
Value$33.3M$108.3K$6.37M−$26.8M (−80.8%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (2)

Institutions that held Turnstone Biologics Corp. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to TSBX in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.42,928$23.9K0.00%
Acadian Asset Management LLC36,454$19.0K0.00%

Sold out (24)

Institutions that held Turnstone Biologics Corp. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (1)

Institutions that held Turnstone Biologics Corp. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TSBX in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.41,344$108.3K